We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ATHA market cap is 20.82M. The company's latest EPS is USD -3.0431 and P/E is -0.17.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.63M | 0 | 0 | 0 |
| Operating Income | -35.04M | -29.01M | -27.69M | -28.03M | -29.62M |
| Net Income | -32.97M | -27.29M | -26.34M | -26.86M | -28.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 1.63M |
| Operating Income | -5.45M | -20M | -64.02M | -104.02M | -125.47M |
| Net Income | -5.16M | -19.96M | -54.85M | -95.64M | -117.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 184.7M | 160.25M | 133.46M | 111.25M | 86.25M |
| Total Liabilities | 29.94M | 30.06M | 26.72M | 27.92M | 28.66M |
| Total Equity | 154.76M | 130.19M | 106.74M | 83.34M | 57.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.19M | 279.56M | 332.01M | 258.15M | 160.25M |
| Total Liabilities | 4.86M | 5.28M | 10.92M | 23.02M | 30.06M |
| Total Equity | -19.72M | 274.28M | 321.08M | 235.14M | 130.19M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -74.46M | -100.75M | -25.8M | -48.13M | -71.16M |
| Investing | 88.7M | 95.09M | 13.04M | 39.6M | 57.64M |
| Financing | 341k | 493k | N/A | 148k | 160k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.71M | -24.11M | -43.1M | -72.47M | -100.75M |
| Investing | 1.51M | -210.07M | -4.08M | 57.66M | 95.09M |
| Financing | 946k | 292.75M | 97.09M | 654k | 493k |
| Market Cap | 20.82M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 12.59 |
| Price to Cash Ratio | 0.23 |
| Price to Book Ratio | 0.16 |
| Dividend Yield | - |
| Shares Outstanding | 38.67M |
| Average Volume (1 week) | 241.35k |
| Average Volume (1 Month) | 322.08k |
| 52 Week Change | -75.52% |
| 52 Week High | 4.2984 |
| 52 Week Low | 0.4115 |
| Spread (Intraday) | 0.05 (8.89%) |
| Company Name | Athira Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.athira.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
